Mim Neurosciences is developing new treatments for neurodegenerative disease based on NAD biology

Mim Neurosciences is developing novel small molecules targeting NMNAT2; the neuron's most important enzyme for NAD synthesis. Situated within Karolinska Institutet and St. Erik Eye Hospital, we are ideally located to translate findings from bench-to-bedside.

Need

Treatments that arrest neurodegeneration and are neuron-specific are the Holy Grail of neurodegenerative disease research

Meet the team

Pete Williams
Inventor, founder, owner, principal scientist

Andrea Brancale
Inventor, medicinal chemist

Melissa Jöe
Research scientist, chemical engineer and pharmacologist

Lilian Wikström
Business development and management


Contact Us